Kbc Group Nv Portfolio Holdings

Kbc Group Nv

  • $33.1 Billion
  • Q3 2024

Kbc Group Nv has filed its 13F form on November 06, 2024 for Q3 2024 where it was disclosed a total value porftolio of $33.1 Billion distributed in 2532 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $2.23B, Nvidia Corp with a value of $1.92B, Amazon Com Inc with a value of $1.59B, Alphabet Inc. with a value of $1.34B, and Apple Inc. with a value of $1.25B.

Examining the 13F form we can see an increase of $2.07M in the current position value, from $33.1B to 33.1B. Also it can be appreciated an additional of 40 stocks purchases and 1 closed positions.

Below you can find more details about Kbc Group Nv portfolio as well as his latest detailed transactions.

Portfolio value $33.1 Billion
Technology: $10.4 Billion
Healthcare: $5.17 Billion
Financial Services: $3.84 Billion
Consumer Cyclical: $3.58 Billion
Communication Services: $3.24 Billion
Industrials: $1.75 Billion
Consumer Defensive: $1.59 Billion
Real Estate: $1.17 Billion
Other: $1.64 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$9.51B
$165,000 0.0% of portfolio
3,120
Q3 2024 Reduced 6.89%
$8.02B
$1.04 Million 0.0% of portfolio
3,095
Q3 2024 Added 82.6%
$1.36B
$43,000 0.0% of portfolio
5,661
Q3 2024 Reduced 34.44%
Biomarin Pharmaceutical Inc
-
$238,000 0.0% of portfolio
-
Q2 2023 Reduced 16.67%
$2.79B
$1.52 Million 0.0% of portfolio
19,043
Q3 2024 Added 41.67%
$4.12B
$120,000 0.0% of portfolio
1,959
Q3 2024 Reduced 0.46%
$4.4B
$106,000 0.0% of portfolio
1,252
Q2 2024 Added 28.41%
$3.68B
$83,000 0.0% of portfolio
1,514
Q2 2024 Added 26.27%
$3.21B
$104,000 0.0% of portfolio
5,456
Q2 2024 Added 41.97%
$78.3M
$386,000 0.0% of portfolio
224,472
Q2 2023 Added 185.95%
$9.02B
$226,000 0.0% of portfolio
3,560
Q3 2024 Reduced 80.84%
Bloom Energy Corp
-
$93,000 0.0% of portfolio
-
Q2 2024 New
$1.12B
$56,000 0.0% of portfolio
3,371
Q3 2024 Added 79.12%
$1.26B
$39,000 0.0% of portfolio
810
Q2 2024 New
$10.8B
$261,000 0.0% of portfolio
13,487
Q3 2024 Added 40.08%
$5.66B
$148,000 0.0% of portfolio
1,602
Q2 2024 Added 21.27%
$3.95B
$159,000 0.0% of portfolio
951
Q3 2024 Added 23.35%
$3.14B
$87,000 0.0% of portfolio
301
Q2 2024 Added 34.98%
$4.77B
$130,000 0.0% of portfolio
3,983
Q2 2024 Added 27.95%
$7.64B
$1.64 Million 0.0% of portfolio
25,407
Q3 2024 Added 0.92%
$3.28B
$74,000 0.0% of portfolio
971
Q1 2024 Reduced 26.16%
$925M
$66,000 0.0% of portfolio
12,166
Q3 2024 Added 70.46%
$1.99B
$68,000 0.0% of portfolio
2,097
Q3 2024 Added 41.5%
$3.42B
$89,000 0.0% of portfolio
3,491
Q3 2024 Added 22.84%
Bridgebio Pharma Inc
-
$103,000 0.0% of portfolio
-
Q4 2023 New
$3.62B
$90,000 0.0% of portfolio
2,001
Q3 2024 Added 30.19%
$5.49B
$96,000 0.0% of portfolio
1,255
Q3 2023 Reduced 60.23%
$4.3B
$123,000 0.0% of portfolio
1,065
Q1 2024 Added 33.46%
$6.81B
$199,000 0.0% of portfolio
7,157
Q3 2024 Added 14.33%
$3.2B
$118,000 0.0% of portfolio
6,220
Q3 2024 Added 29.39%
$924M
$41,000 0.0% of portfolio
4,017
Q3 2023 Reduced 44.22%
$3.42B
$70,000 0.0% of portfolio
1,439
Q3 2023 Added 8.96%
$6.03B
$170,000 0.0% of portfolio
2,025
Q3 2024 Added 21.69%
$2.37B
$45,000 0.0% of portfolio
1,030
Q3 2023 Reduced 52.18%
$3.4B
$87,000 0.0% of portfolio
3,593
Q3 2024 Added 37.03%
$4B
$105,000 0.0% of portfolio
1,553
Q3 2024 Added 29.74%
$7.65B
$114,000 0.0% of portfolio
10,314
Q3 2024 Added 81.68%
$20.1B
$1.45 Million 0.0% of portfolio
20,536
Q1 2024 Added 6.12%
$4.44B
$118,000 0.0% of portfolio
3,349
Q3 2024 Added 26.71%
$1.75B
$346,000 0.0% of portfolio
7,110
Q2 2024 Added 26.44%
$6.36B
$161,000 0.0% of portfolio
440
Q2 2024 Added 25.0%
$1.68B
$52,000 0.0% of portfolio
1,083
Q3 2023 Reduced 53.88%
$7.33B
$144,000 0.0% of portfolio
4,410
Q2 2024 Added 28.87%
$3.24B
$79,000 0.0% of portfolio
4,449
Q2 2024 Added 38.38%
$1.88B
$37,000 0.0% of portfolio
1,593
Q2 2024 Added 87.63%
$2.37B
$56,000 0.0% of portfolio
160
Q3 2024 Added 45.45%
$6.12B
$160,000 0.0% of portfolio
1,430
Q2 2024 Added 17.12%
$3.96B
$117,000 0.0% of portfolio
1,954
Q2 2024 Added 27.38%
$6.93B
$160,000 0.0% of portfolio
5,036
Q3 2024 Added 11.49%

Summary

  • Portfolio
  • No. of Stocks 2,532
  • Current Value $33.1 Billion
  • Prior Value $33.1 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 06, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 40 stocks
  • Additional Purchases 846 stocks
  • Sold out of 1 stocks
  • Reduced holdings in 312 stocks
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email